Related references
Note: Only part of the references are listed.Sirt6 protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting P53/Fas-dependent cell death and augmenting endogenous antioxidant defense mechanisms
Sisi Wu et al.
CELL BIOLOGY AND TOXICOLOGY (2023)
High-starchy carbohydrate diet aggravates NAFLD by increasing fatty acids influx mediated by NOX2
Yuqi Gao et al.
FOOD SCIENCE AND HUMAN WELLNESS (2023)
Sirt6 Alleviated Liver Fibrosis by Deacetylating Conserved Lysine 54 on Smad2 in Hepatic Stellate Cells
Jinhang Zhang et al.
HEPATOLOGY (2021)
SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation
Yanying Zhou et al.
ACTA PHARMACEUTICA SINICA B (2021)
Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators
Shaoyong Lu et al.
ACTA PHARMACEUTICA SINICA B (2021)
Prohibitin depletion extends lifespan of a TORC2/SGK-1 mutant through autophagy and the mitochondrial UPR
Patricia de la Cruz-Ruiz et al.
AGING CELL (2021)
Cardiac Energy Metabolism in Heart Failure
Gary D. Lopaschuk et al.
CIRCULATION RESEARCH (2021)
A novel SIRT6 activator ameliorates neuroinflammation and ischemic brain injury via EZH2/FOXC1 axis
Tailin He et al.
ACTA PHARMACEUTICA SINICA B (2021)
Association of SIRT6 circulating levels with urinary and glycometabolic markers in pre-diabetes and diabetes
Che Bian et al.
ACTA DIABETOLOGICA (2021)
Intermittent fasting in the prevention and treatment of cancer
Katherine K. Clifton et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Restoration of energy homeostasis by SIRT6 extends healthy lifespan
A. Roichman et al.
NATURE COMMUNICATIONS (2021)
SIRT6 transcriptionally regulates fatty acid transport by suppressing PPARγ
Danish Khan et al.
CELL REPORTS (2021)
Age-related changes of human serum Sirtuin6 in adults
Ying Zhao et al.
BMC GERIATRICS (2021)
Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
Kendall B. Wallace et al.
CIRCULATION RESEARCH (2020)
The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a
Dong Han et al.
CIRCULATION RESEARCH (2020)
Fasting mimicking diet as an adjunct toneoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial
Stefanie de Groot et al.
NATURE COMMUNICATIONS (2020)
Effects of galloflavin and ellagic acid on sirtuin 6 and its anti-tumorigenic activities
Minna Rahnasto-Rilla et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Mitochondrial Permeability Uncouples Elevated Autophagy and Lifespan Extension
Ben Zhou et al.
CELL (2019)
Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity
Bruno Saleme et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities
Jie Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Fructus Ligustri Lucidi preserves bone quality through the regulation of gut microbiota diversity, oxidative stress, TMAO and Sirt6 levels in aging mice
Lin Li et al.
AGING-US (2019)
Mitochondrial Perturbations Couple mTORC2 to Autophagy in C. elegans
Helena Aspernig et al.
CELL REPORTS (2019)
Ellagic acid a multi-target bioactive compound for drug discovery in CNS? A narrative review
Silvana Alfei et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Caloric Restriction Engages Hepatic RNA Processing Mechanisms in Rhesus Monkeys
Timothy W. Rhoads et al.
CELL METABOLISM (2018)
Overexpressed SIRT6 attenuates cisplatin-induced acute kidney injury by inhibiting ERK1/2 signaling
Zhongchi Li et al.
KIDNEY INTERNATIONAL (2018)
Metabolic remodelling in heart failure
Edoardo Bertero et al.
NATURE REVIEWS CARDIOLOGY (2018)
Mitochondrial dysfunction in pathophysiology of heart failure
Bo Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Identification of a cellularly active SIRT6 allosteric activator
Zhimin Huang et al.
NATURE CHEMICAL BIOLOGY (2018)
The breast cancer patient in the cardioncology unit
Daniela Cardinale et al.
JOURNAL OF THORACIC DISEASE (2018)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
Jose Luis Zamorano et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b
Sita Kugel et al.
CELL (2016)
SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence
Luisa Tasselli et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
SIRT6 deacetylates H3K18ac at pericentric chromatin to prevent mitotic errors and cellular senescence
Luisa Tasselli et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
P53 inhibition exacerbates late-stage anthracycline cardiotoxicity
Wuqiang Zhu et al.
CARDIOVASCULAR RESEARCH (2014)
Fasting: Molecular Mechanisms and Clinical Applications
Valter D. Longo et al.
CELL METABOLISM (2014)
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Yoshihiko Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Drugging the p53 pathway: understanding the route to clinical efficacy
Khoo Kian Hoe et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy
Filipa S. Carvalho et al.
MEDICINAL RESEARCH REVIEWS (2014)
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
Tomáš Šimůnek et al.
Pharmacological Reports (2014)
Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling
Rimpy Dhingra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Chromatin and beyond: the multitasking roles for SIRT6
Site Kugel et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Preventive Effects of Ellagic Acid Against Doxorubicin-Induced Cardio-Toxicity in Mice
Ming-cheng Lin et al.
CARDIOVASCULAR TOXICOLOGY (2013)
The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism
Carlos Sebastian et al.
CELL (2012)
Lipid Metabolism and Toxicity in the Heart
Ira J. Goldberg et al.
CELL METABOLISM (2012)
Pathological Role of Serum- and Glucocorticoid-Regulated Kinase 1 in Adverse Ventricular Remodeling
Saumya Das et al.
CIRCULATION (2012)
Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy
Changhan Lee et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death
Andrey V. Kuznetsov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Reduced Levels of IGF-I Mediate Differential Protection of Normal and Cancer Cells in Response to Fasting and Improve Chemotherapeutic Index
Changhan Lee et al.
CANCER RESEARCH (2010)
The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α
Lei Zhong et al.
CELL (2010)
SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span
Tiara L. A. Kawahara et al.
CELL (2009)
Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6
Eriko Michishita et al.
CELL CYCLE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Anthracycline-trastuzumab regimens for HER2/neuoverexpressing breast cancer: current experience and future strategies
D. Rayson et al.
ANNALS OF ONCOLOGY (2008)
Starvation-dependent differential stress resistance protects normal but not cancer COS against high-dose chemotherapy
Lizzia Raffaghello et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
Masanori Sano et al.
NATURE (2007)
The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity
Stefan M. Schieke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Acute doxorubicin cardiotoxicity
ER Hayek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice
Y Shizukuda et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
SM Swain et al.
CANCER (2003)
Share Paper
